Abstract
Age related muscle loss, known as sarcopenia, is a major factor in disability, loss of mobility and quality of life in the elderly. There are many proposed mechanisms of age-related muscle loss that include the endocrine system. A variety of hormones regulate growth, development and metabolism throughout the lifespan. Hormone activity may change with age as a result of reduced hormone secretion or decreased tissue responsiveness. This review will focus on the complex interplay between the endocrine system, aging and skeletal muscle and will present possible benefits of therapeutic interventions for sarcopenia.
Keywords: aging, endocrine, exercise, growth hormone, hormones, sarcopenia, testosterone, vitamin D, estrogen, muscle
Current Aging Science
Title: The Endocrine System and Sarcopenia: Potential Therapeutic Benefits
Volume: 4 Issue: 3
Author(s): Kevin L. McIntire and Andrew R. Hoffman
Affiliation:
Keywords: aging, endocrine, exercise, growth hormone, hormones, sarcopenia, testosterone, vitamin D, estrogen, muscle
Abstract: Age related muscle loss, known as sarcopenia, is a major factor in disability, loss of mobility and quality of life in the elderly. There are many proposed mechanisms of age-related muscle loss that include the endocrine system. A variety of hormones regulate growth, development and metabolism throughout the lifespan. Hormone activity may change with age as a result of reduced hormone secretion or decreased tissue responsiveness. This review will focus on the complex interplay between the endocrine system, aging and skeletal muscle and will present possible benefits of therapeutic interventions for sarcopenia.
Export Options
About this article
Cite this article as:
L. McIntire Kevin and R. Hoffman Andrew, The Endocrine System and Sarcopenia: Potential Therapeutic Benefits, Current Aging Science 2011; 4 (3) . https://dx.doi.org/10.2174/1874609811104030298
DOI https://dx.doi.org/10.2174/1874609811104030298 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
SUBJECT INDEX TO VOLUME 1
Current Drug Safety Hydrogen Sulphide and Pain
Inflammation & Allergy - Drug Targets (Discontinued) Transglutaminase-Mediated Activation of Nuclear Transcription Factor-κB in Cancer Cells: A New Therapeutic Opportunity
Current Cancer Drug Targets Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling
Current Cancer Drug Targets Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents
Current Medicinal Chemistry An Update on the Other Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Medicinal Chemistry Reviews - Online (Discontinued) Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma
Current Medicinal Chemistry Pharmacological Interference With Protein-protein Interactions of Akinase Anchoring Proteins as a Strategy for the Treatment of Disease
Current Drug Targets FK506 Binding Proteins as Targets in Anticancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Nucleic Acid Aptamers Against Proteases
Current Medicinal Chemistry Treatment of Atopic Dermatitis: Current Status and Future Prospects
Current Drug Therapy Applications of High Content Screening in Life Science Research
Combinatorial Chemistry & High Throughput Screening The Activity of Titanocene T Against Xenografted Caki-1 Tumors
Letters in Drug Design & Discovery Recent Progress in the Synthesis and Biomedical Properties of Natural Biopolymer Composites
Current Medicinal Chemistry Application of Decoy Oligonucleotides as Novel Therapeutic Strategy: A Contemporary Overview
Current Drug Discovery Technologies Editorial [Hot Topic: Adrenergic Receptors as Novel Targets for Cancer Therapy (Guest Editors: D.G. Powe and F. Entschladen)]
Current Cancer Therapy Reviews The Biology of the Peroxisome Proliferator-activated Receptor System in the Female Reproductive Tract
Current Pharmaceutical Design Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers
Current Cancer Drug Targets Patented Biotechnological Applications of Serpin: an Update
Recent Patents on DNA & Gene Sequences Cancer Resistance to Type II Topoisomerase Inhibitors
Current Medicinal Chemistry